Device built-in

Product Introduction: Sartorius Flexible Connection Virus Removal System Platform

Sartorius Flexible Connection Virus Removal System Platform is an innovative viral clearance solution specifically developed for the biopharmaceutical industry. Incorporating advanced flexible connection technology and modular design, it provides safe and reliable virus removal assurance for biologics including monoclonal antibodies, vaccines, and blood products.

Core Advantages

1. Patented Flexible Connection Technology

• Utilizes high-purity biopharmaceutical-grade tubing system with >40% shear force reduction
• Fully enclosed flow path design compliant with biosafety level requirements
• Quick-disconnect sterile connections with <10 minute changeover time

2. High-Efficiency Virus Removal Performance

• Compatible with Sartobind® series virus filters (LRV≥4log)
• Handles various filtration scales from 20-50cm²
• <150mL hold-up volume with up to 95% product recovery rate

3. Intelligent Control System

• Integrated online monitoring of pressure, flow and temperature
• 21 CFR Part 11 compliant control software
• Complete audit trail and data logging functions

Technical Specifications

• Operating pressure: 0.5-4bar
• Flow rate range: 1-15L/min
• Temperature range: 4-50°C
• CIP capability: Supports 1M NaOH cleaning-in-place

Typical Applications

• mAbs: Downstream process viral safety validation
• Vaccine production: Virus inactivation process optimization
• Blood products: Viral removal for plasma proteins
• Gene therapy: Viral control in vector purification

Service Support

• Full-scale validation services from lab to production
• Complete DQ/IQ/OQ documentation package
• Professional technical team for installation and training

This platform is ISO 13485 certified with all fluid-contact materials meeting USP Class VI standards. Compared to traditional stainless steel systems, it improves virus removal efficiency by >15% while reducing cross-contamination risks by 30%, making it the ideal choice for biopharmaceutical companies to enhance product safety.

(Word count: 298, maintaining all technical specifications and key value propositions while optimizing for international biopharma industry terminology)